Sign in

NCT07806227Not yet recruitingPhase 4

Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder

Broadband Near Infrared Spectroscopy to Elucidate the of Role Cortical Brain Cytochrome C Oxidase Activity in the Pathophysiology of Bipolar Disorder

Source: ClinicalTrials.gov · Last updated 8 Sept 2026

Brief summary (registry, in English)

People with a diagnosis of bipolar disorder who are depressed will have a light-based imaging of the brain (Near Infrared Spectroscopy) before and after they have treatment for their depression with a standard, approved medication named lurasidone. They will also answer questions about their history, and give blood samples. The goal is to understand the role of mitochondrial activity in bipolar disorder. Healthy volunteers who have never had a psychiatric disorder will have the same procedures, but they will not receive the medication.

Status (registry)
Not yet recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
First submitted
2 Sept 2026
Start date
1 Nov 2026
Primary completion date
30 Jul 2028
Lead sponsor
Martin Lan
NCT number
NCT07806227

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 60
  • From 1 Nov 2026 to the primary completion date, 30 Jul 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Taking any medications that cannot be combined with lurasidone
  • Any electroconvulsive therapy (ECT) within the last six months

Other illness

  • Any drug or alcohol use disorders that are moderate or severe

Other

  • Any medical problems that are not well treated
  • Any severe suicidal ideation, or having had a suicide attempt in the last five years
  • Any psychotic symptoms that have occurred outside of a mood episode
  • Currently pregnant or planning to become pregnant during the time of the study

Who the study is looking for

  • Diagnosis of bipolar disorder
  • Having symptoms of depression
  • Taking less than three medications for bipolar disorder

Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
New York State Psychiatric Institute
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.